Dr. Tanya Stoyanova gives a talk at 2024 AACR on “UCHL1 as a Molecular Indicator and Therapeutic Target for Neuroendocrine Carcinomas”

Dr. Stoyanova gave a talk on a project “UCHL1 as a Molecular Indicator and Therapeutic Target for Neuroendocrine Carcinomas” at the 2024 AACR.

PreviousNakea Pennant receives 2024 AACR Minority Scholar in Cancer Award
NextDr. Alifiani Hartono presents her project “CDC7 is a targetable regulator of advanced prostate cancer”

Related Posts ...

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

Exciting News: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for small-cell lung cancer